The results of the analysis of stage IV patients in the previous section strongly suggest the existence of an immune escape mechanism that inhibits NK cell recruitment and anti-tumor function by reducing the level of CX3CL1 in peripheral blood during the progression of colorectal cancer (Figure 6H). This evidence concerns the gene CX3CL1 and neoplasm.